Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment
OncoTargets and Therapy · 2024-01 · Volume 17 · 63-78
DOI: 10.2147/ott.s448024 ↗At a glance
Journal article in OncoTargets and Therapy, 2024-01. Written by Janviere Kabagwira and 10 co-authors. Institution: Department of Basic Science, Division of Biochemistry, Loma Linda University, Loma Linda, CA, USA. Cited 4 times so far (Crossref); 82 references. The full text is freely available (open access, CC BY-NC 3.0).
Abstract (original language)
Introduction
Peritoneal metastases from colorectal cancer (CRC) present a significant clinical challenge with poor prognosis, often unresponsive to systemic chemotherapy. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment approach for select patients. The use of curcumin, a natural compound with antitumor properties, in HIPEC is of interest due to its lower side effects compared to conventional drugs and potential for increased efficacy through direct delivery to the peritoneal cavity.
Methods
An in vitro hyperthermic model was developed to simulate clinical HIPEC conditions. Three colon cancer cell lines (SK-CO-1, COLO205, SNU-C1) representing different genetic mutations (p53, KRAS, BRAF) were treated with either curcumin (25 µM) or mitomycin-C (1 µM) for 1, 2, or 3 hours. Post-treatment, cells were incubated at 37°C (normothermia) or 42°C (hyperthermia). Cell viability and proliferation were assessed at 24, 48 and 72 hours post-treatment using Annexin V/PI, MTT assay, trypan blue exclusion, and Hoffman microscopy.
Results
Hyperthermia significantly enhanced the antitumor efficacy of curcumin, evidenced by a two-fold reduction in cell viability compared to normothermia across all cell lines. In the SNU-C1 cell line, which harbors a p53 mutation, mitomycin-C failed to significantly impact cell viability, unlike curcumin, suggesting mutation-specific differences in treatment response.
Discussion
The findings indicate that hyperthermia augments the antitumor effects of curcumin in vitro, supporting the hypothesis that curcumin could be a more effective HIPEC agent than traditional drugs like mitomycin-C. Mutation-associated differences in response to treatments were observed, particularly in p53 mutant cells. While further studies are needed, these preliminary results suggest that curcumin in HIPEC could represent a novel therapeutic strategy for CRC patients with peritoneal metastases. This approach may offer improved outcomes with fewer side effects, particularly in genetically distinct CRC subtypes.
Subjects
Author keywords
Authors and institutions
- Department of Basic Science, Division of Biochemistry, Loma Linda University, Loma Linda, CA, USA.
- Center for Health Disparities and Molecular Medicine, Loma Linda University, Loma Linda, CA, USA.
- Division of Surgical Oncology, Department of Surgery, Loma Linda University Health, Loma Linda, CA, USA.
- Division of Surgical Oncology, Department of Surgery, Irvine Medical Center, University of California, Orange, CA, USA.
ORCID profiles: Ryan N Fuller, Nathan R Wall
Cite
APA
Kabagwira, J., Fuller, R. N., Vallejos, P. A., Sugiono, C. S., Andrianarijaona, V. M., Chism, J. B., O'Leary, M. P., Molina, D. C., Langridge, W., Senthil, M., & Wall, N. R. (2024). Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment. OncoTargets and Therapy, Volume 17, 63-78. https://doi.org/10.2147/ott.s448024
Vancouver
Kabagwira J, Fuller RN, Vallejos PA, Sugiono CS, Andrianarijaona VM, Chism JB, et al. Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment. OncoTargets and Therapy. 2024;Volume 17:63-78. doi:10.2147/ott.s448024
BibTeX
@article{Kabagwira2024,
author = {Kabagwira, Janviere and Fuller, Ryan N and Vallejos, Paul A and Sugiono, Chase S and Andrianarijaona, Vola-Masoandro and Chism, Jazmine Brianna and O'Leary, Michael P and Molina, David Caba and Langridge, William and Senthil, Maheswari and Wall, Nathan R},
title = {Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment},
journal = {OncoTargets and Therapy},
year = {2024},
volume = {Volume 17},
pages = {63--78},
doi = {10.2147/ott.s448024}
}
EUVIMED